{"organizations": [], "uuid": "b8f14ed405f969b5619beeb7fb40961394685516", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/02/05/business-wire-bioqual-presents-unaudited-financial-results-for-second-quarter-of-fiscal-year-2018.html", "country": "US", "domain_rank": 767, "title": "BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2018", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.141, "site_type": "news", "published": "2018-02-05T20:04:00.000+02:00", "replies_count": 0, "uuid": "b8f14ed405f969b5619beeb7fb40961394685516"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/02/05/business-wire-bioqual-presents-unaudited-financial-results-for-second-quarter-of-fiscal-year-2018.html", "ord_in_thread": 0, "title": "BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2018", "locations": [], "entities": {"persons": [], "locations": [{"name": "md.", "sentiment": "none"}, {"name": "bioqual", "sentiment": "none"}, {"name": "rockville", "sentiment": "none"}], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "ROCKVILLE, Md.--(BUSINESS WIRE)-- BIOQUAL, Inc. (OTC Pink: BIOQ) ( www.bioqual.com ):\nSix Months Ended November 30,\nThree Months Ended November 30,\n2017 2016 2017 2016 Revenue $ 17,800,956 $ 18,648,523 $\n9,096,203 $ 9,482,331 Income Before Income Tax $ 2,621,662 $ 3,489,749 $\n1,259,364 $\n1,759,360 Net Income $ 1,513,962 $ 2,015,349 $\n727,264 $\n1,016,160 Basic Earnings per Share of Common Stock\n$\n1.69\n$\n2.26\n$\n.81\n$\n1.14\nDiluted Earnings per Share of Common Stock\n$\n1.69\n$\n2.26\n$\n.81\n$\n1.14\nWeighted Average Number of Shares Outstanding For Basic and Diluted Earnings\n893,694\n893,416\n893,976\n893,416\nFor more detail related to the fiscal year 2018 unaudited second quarter results, please visit our web site at www.bioqual.com .\nStatements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the ability to continue to extend current government contracts and obtain new contracts; the Company’s ability to obtain new government or commercial contracts; continued demand for the use of animal models in scientific research; the Company’s ability to perform under its contracts in accordance with the requirements of the contracts; the actual costs incurred in performing the Company’s contracts and its ability to manage its costs, including its capital expenditures; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing/capital sources to the Company.\nView source version on businesswire.com : http://www.businesswire.com/news/home/20180205005668/en/\nBIOQUAL, Inc.\nMark G. Lewis, Ph.D., CEO, 240-404-7654\nSource: BIOQUAL, Inc.", "external_links": ["http://www.businesswire.com/news/home/20180205005668/en/", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.bioqual.com&esheet=51753597&newsitemid=20180205005668&lan=en-US&anchor=www.bioqual.com&index=2&md5=400ecee1f13518323623497569e23f99", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.bioqual.com&esheet=51753597&newsitemid=20180205005668&lan=en-US&anchor=www.bioqual.com&index=1&md5=5251dae232c20f80b11d5a59fe74d55b"], "published": "2018-02-05T20:04:00.000+02:00", "crawled": "2018-02-05T23:41:10.023+02:00", "highlightTitle": ""}